Charles e

Charles E. Bailey, MD
AFFILIATIONS:
Executive DirectorGlobal Institute for Scientific ThinkingLake Mary, Florida Medical DirectorAccurate Clinical TrialsKissimmee, Florida Volunteer FacultyUniversity of Central Florida College of MedicineOrlando, Florida PROFESSIONAL EXPERIENCE:
Accurate Clinical Trials
Principal Investigator and Medical Director Oversees and directs all operations of Accurate Clinical Trials, Inc. Functions as Principal Investigatorfor inpatient clinical research psychopharmacology trials and provides clinical and medical oversight of study subjects. Provides Training to clinical staff and investigators regarding study conduct, protocol adherence, Good Clinical Practices, and responsible for establishing and maintaining effective corporate culture.
CNS Healthcare
Investigator and past Medical Director Functions included serving as Principal Investigator and Sub Investigator for outpatientpsychopharmacology clinical research, providing clinical and medical oversight of study subjects.
Osceola Community Mental Health Center
Outpatient Child and Adolescent Psychiatry Seminole Community Mental Health Center
Outpatient Child and Adolescent Psychiatry Lakeside Behavioral Health
Staff Psychiatrist, Day Treatment Program Orlando Regional Behavioral Health Center
Medical Director, Outpatient Chemical Dependency MCC Healthcare
South Seminole Hospital
South Seminole Hospital
Clinical Director, Inpatient Chemical Dependency Treatment Lakewood Residential Treatment Center
Rational Therapy Center
EDUCATION:
University of Florida, Department of Psychiatry University of Texas Health Science Center at Houston Associate of Arts Baytown, TexasLee College 1977 LISCENSURE / ACCREDITATION:
Florida Medical License, June, 1985 - Present Drug Enforcement Agency License, 1985 - Present American Board of Psychiatry and Neurology, January, 1992 - Present American Board of Addictions Medicine, June, 1993 - 2003 PROFESSIONAL AFFILIATIONS:
American Psychiatric Association 1985 – 2009 Florida Psychiatric Association, 1985 – 2009 Society for Neuroscience, 2004 – Present CLINICAL EXPERIENCE:
General Psychiatry with diagnosis and treatment of DSM psychiatric disorders including medication,management, Rational Emotive and Cognitive Behavioral Therapies, 1985 - Present EDUCATIONAL CONFERENCES:
AAPP: Good Clinical Practices for Clinical Investigators, 2001 Harvard Medical School: Attention Deficit/Hyperactivity Disorder, 2001 Harvard Medical School: Child and Adolescent Psychopharmacology, 1999 and 2000 Society for Neuroscience Annual Conference, 2004, 2005, 2006, 2007, and 2008 International Behavioral Neuroscience Annual Conference, 2006 Institute of General Semantics International Conference, 2006 New York Academy of Sciences Conference, Linking Affect to Action: Critical Contributions of the Orbitofrontal Cortex, 2007 The First International Conference on Social Entrepreneurship, Systems Thinking, and Complexity, 2008 Genetic and Evolutionary Computation Conference - GECCO 2008 2nd International Academy on Critical Thinking – Oxford UK 2008 The fourth Cold Spring Harbor Laboratory/Welcome Trust conference on Integrative Approaches to Brain Complexity, Hinxton/Cambridge UK 2008 New York Academy of Sciences, Values and Empathy across Social Barriers: A Neurocognitive Approach to Fairness, Barcelona, 2008 COSYNE 2009, Computational and Systems Neuroscience, Salt Lake City RESEARCH FUNDING CONTRIBUTIONS:
University of Central Florida
School of Electrical Engineering and Computer Science
Evolutionary Computation
PUBLICATIONS:
Bailey, C. E. (2009). Exploiting the relationship of natural language and computer science: A novel theoretical approach to fairness. Cognitive Sciences 4 (2): xx-xx. Bailey, C. E. (2007). Semantically mediated integration of cognition in Homo sapiens: Evolution, grammar, uncertainty, and cognitive accuracy. Cognitive Sciences 3 (1): 85-142. Bailey, C. E. (2007). Cognitive accuracy and intelligent executive function in the brain and in business. In C. Senior & M. J. R. Butler (Eds.), The social cognitive neuroscience of organizations. New York, NY: Annals of the New York Academy of Sciences, 1118, 122-141.
Bailey, C. E. (2006). A general theory of psychological relativity and cognitive evolution. ETC: A Review Popper, C. W., Gammon, G. D., West, S. A. & Bailey, C. E. (2003). Disorders Usually First Diagnosed in Infancy, Childhood, or Adolescence. In R. E. Hale & S. C. Yudofsky (Eds.). The Textbook of Clinical Psychiatry (4th Ed.). Washington, DC: American Psychiatric Publishing.
Spencer T, Kratochvil C, Sangal RB, Saylor K, Bailey C, Dunn D, Geller D, Casat C, Lipetz R, Jain R, Newcorn J, Ruff D, Feldman P, Furr A, Allen AJ. Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment. J Child Adolesc Psychopharmacol 2007;17(5):689-699 Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder. Arch Pediatr Adolesc Med. 2006;160:82-90.
ACKNOWLEDGEMENTS:
Lehman, J. & Stanley, K. (2008). Exploiting open-endedness to solve problems through the search for novelty. In: Proceedings of the eleventh international conference on artificial life (ALIFE XI). Cambridge, MA: MIT Press Kratochvil CJ, Michelson D, Newcorn J, Weiss M, Busner J, Moore R, Ruff D, Ramsey J, Dickson R, Turgay A, Saylor K, Luber S, Vaughan B, Allen AJ, The Atomoxetine High-Dose Study Group. High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses. J Am Acad Child Adolesc Psychiatry. 2007;46(9):1128-1137 versus placebo in the acute treatment of major depression. J Psychiatr Res. 2002 Nov-Dec;36(6):383-90.
Douglas K. Kelsey, MD, PhD*, Calvin R. Sumner, MD*, Charles D. Casat, MD , Daniel L. Coury, MD , Humberto Quintana, MD||, Keith E. Saylor, PhD¶, Virginia K. Sutton, PhD*, Jill Gonzales, BS*,
Sandra K. Malcolm, BS*, Kory J. Schuh, PhD* and Albert J. Allen, MD, PhD* . Once-Daily
Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an
Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled Trial. Pediatrics
Vol. 114 No. 1 July 2004, pp. e1-e8
PRESENTATIONS:
Institute of General Semantics International Conference, Dallas, Texas, 2006, “Semantics: The Key to Understanding the Brain” International Behavioral Neuroscience Annual Conference, Whistler, Canada, 2006, “A General Theory of Psychological Relativity and Cognitive Evolution” The First International Conference on Social Entrepreneurship, Systems Thinking, and Complexity, New York, 2008, “Accurate Executive Function and Complexity: Something to Think About?” The Society for Neuroscience 2008 annual conference Washington, D.C., “Semantically Mediated Integration of Cognition in Homo sapiens: Evolution, Grammar, Uncertainty, and Cognitive Accuracy” New York Academy of Sciences, Values and Empathy across Social Barriers: A Neurocognitive Approach to Fairness, Barcelona, 2008, “Exploiting the Relationship of Natural Language and Computer Science: A Novel Theoretical Approach to Fairness” ACNP, Scottsdale, 2008. Jain, R., Kollins, S., Bailey, C., Holloway, W., Horacek, J. & Khayrallah, M. “Developing a Sustained Release Formulation of Clonidine for the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder” (not attended)

Source: http://www.gistinc.org/pubs/cv.pdf